American Healthcare REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on November 14, 2022, by American Healthcare REIT, Inc. The filing details corporate actions taken in connection with a proposed listing of the company's common stock on the New York Stock Exchange (Proposed Listing). The report covers events occurring between November 14 and November 16, 2022.
Key Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses on corporate governance and capital structure adjustments. Financial results for the third quarter of 2022 are referenced as being contained in a separate Investor Update Letter (Exhibit 99.1) but are not detailed within the text of this 8-K.
Material Changes
- Reverse Stock Split: On November 15, 2022, the company effected a one-for-four reverse stock split of its Class T and Class I common stock. Every four shares were combined into one new share.
- Par Value Adjustment: Immediately following the split, the par value of the common stock was decreased from $0.04 per share to $0.01 per share via an amendment to the charter.
- Equity Plan Adjustments: Equitable adjustments were made to the 2015 Incentive Award Plan, including the number of shares available for issuance and outstanding awards, to reflect the reverse stock split.
- Ownership Impact: The reverse stock split did not alter any stockholder's percentage ownership interest or the total number of authorized shares.
Guidance, Outlook, and Corporate Actions
- Suspension of DRIP: The Board approved the suspension of the Distribution Reinvestment Plan (DRIP) effective for distributions declared for the quarter ending December 31, 2022. Future distributions will be paid in cash. There is no guarantee the DRIP will be reinstated.
- Suspension of SRP: The Board approved the suspension of the Share Repurchase Plan (SRP) effective for the quarter ending December 31, 2022. All outstanding repurchase requests were cancelled in full.
- Investor Update: On November 16, 2022, the company issued a Third Quarter 2022 Investor Update Letter discussing financial results and the aforementioned corporate actions.
Key Facts for Investor Verification
- Verify the post-split share count and trading symbol status on the New York Stock Exchange.
- Confirm the timing and amount of the next cash distribution following the DRIP suspension.
- Review the Third Quarter 2022 Investor Update Letter (Exhibit 99.1) for specific financial performance data not included in this filing.
- Monitor future Board announcements regarding the potential reinstatement of the DRIP and SRP.